Publications

Clynes, M.
Maquire AR, Plunkett SJ, Papot S, Clynes M, O'Connor R and Touhey S
"Synthesis of indomethacin analgues for evaluation as modulators of MRP activity."
BioOrganic & Medicinal Chemistry, 9(3), 2001, pp 745-762.

Maguire AR, Papot S, Ford A, Touhey S, O'Connor R and Clynes M
"Enantioselective synthesis of sulindac."
Synlett, 1, 2001, pp 41-44.

Meleady P and Clynes M
"Bromodeoxyuridine induces integrin expression at transcriptional (a2 subunit) and post-transcriptional (b1 subunit) levels, and alters the adhesive properties of two human lung tumour cell lines."
Cell Comm. Adhes., 2001, (In press)

Meleady P and Clynes M
"Bromodeoxyuridine increases keratin 19 protein expression at a post-transcriptional level in two human lung tumour cell lines."
In Vitro Cell Dev. Biol., 2001, (In press)

Liang Y, Meleady P, Cleary I, McDonnell S, Connolly L and Clynes M
"Selection with melphalan, or taxol, yields variants with different patterns of multidrug resistance, and integrin expression and in vitro invasiveness."
Eur. J. Can., 37, 2001, pp 1041-1052.

Connolly L, Moran E, Larkin A, Scheper R, Scheffer G, Kool M and Clynes M
"P2A8(6), A new monoclonal antibody that specifically recognises a novel eoptope on the Multidrug Resistance-Associated Protein 1 (MRP1)."
Hybridoma, 2001, (In press)